We have previously reported that sCD200 is detectable in CLL tissue culture supernatants, and that the release of sCD200 from CLL cells can be inhibited by the global protease inhibitor GM6001 or by silencing of ADAM28 [19, 20]. This evidence concerns the gene ADAM28 and B-cell chronic lymphocytic leukemia.